Abstract:The diterpenoid paclitaxel (Taxol ® ) is a blockbuster anticancer agent that was originally isolated from the Pacific yew ( Taxus brevifolia ) five decades ago. Despite the wealth of information gained over the years on Taxol research, there still remains supply issues to meet increasing clinical demand. Although alternative Taxol production methods have been developed, they still face several drawbacks that cause supply shortages and high production costs. It is highly desired to develop biotechnological production platforms for Taxol, however, there are still gaps in our understanding of the biosynthetic pathway, catalytic enzymes, regulatory and control mechanisms that hamper production of this critical drug by synthetic biology approaches. Over the past 5 years, significant advances were made in metabolic engineering and optimization of the Taxol pathway in different hosts, leading to accumulation of taxane intermediates. Computational and experimental approaches were leveraged to gain mechanistic insights into the catalytic cycle of pathway enzymes and guide rational protein engineering efforts to improve catalytic fitness and substrate/product specificity, especially of the cytochrome P450s (CYP450s). Notable breakthroughs were also realized in engineering the pathway in plant hosts that are more promising in addressing the challenging CYP450 chemistry. Here, we review these recent advances and in addition, we summarize recent transcriptomic data sets of Taxus species and elicited culture cells, and give a bird’s-eye view of the information that can be gleaned from these publicly available resources. Recent mining of transcriptome data sets led to discovery of two putative pathway enzymes, provided many lead candidates for the missing steps and provided new insights on the regulatory mechanisms governing Taxol biosynthesis. All these inferences are relevant to future biotechnological production of Taxol.

Recent progresses in the studies of taxol and taxane-producing fungi

Advances On Paclitaxel Biosynthesis In Taxus

Biosynthesis and Regulation of Paclitaxel in Taxus

A natural anticancer agent: paclitaxel

Strategies Of Improving Paclitaxel Biosynthesis In Taxus

Recent Advances in Metabolic Engineering, Protein Engineering, and Transcriptome-Guided Insights Toward Synthetic Production of Taxol

Fungal endophytes of Taxus species and regulatory effect of two strains on taxol synthesis

Recent Research Progress in Taxol Biosynthetic Pathway and Acylation Reactions Mediated by Taxus Acyltransferases

A New Taxol-Producing Fungus (Pestalotiopsis Malicola) And Evidence For Taxol As A Transient Product In The Culture

Research Progress on Production of Taxol by Plant Cell Engineering

A New Endophytic Taxane-Production Fungus from Taxus Chinensis.

Identification and Pilot Study of Taxus Engophytic Fungi's Taxol-producing Correlation Gene BAPT

Genome Sequencing and Analysis of the Paclitaxel-Producing Endophytic Fungus Penicillium Aurantiogriseum NRRL 62431

Taxol produced from endophytic fungi induces apoptosis in human breast, cervical and ovarian cancer cells

Production of Taxol by an Endophytic Fungus Isolated from Taxus Chinensis Var. Mairei

Biosynthesis of paclitaxel using synthetic biology

Taxol: biosynthesis, molecular genetics, and biotechnological applications

Post-genomic illumination of paclitaxel biosynthesis

An Endophytic Taxol-Producing Fungus Bt2 Isolated from Taxus Chinensis Var. Mairei

Taxol Fromtuberculariasp. Strain TF5, an Endophytic Fungus Oftaxus Mairei

Research Progress of Paclitaxel Drug Source Solution and Extraction and Separation Technology